Skip to main content
AAN.com
Article
May 25, 2018

Associations between lesions and domain-specific cognitive decline in poststroke dementia

July 3, 2018 issue
91 (1) e45-e54

Abstract

Objective

To investigate whether the effect of prestroke and stroke-related lesions on incident poststroke dementia (PSD) is mediated by a unique pattern of domain-specific cognitive impairment, and the relative strength of these anatomical–cognitive associations in predicting incident PSD.

Methods

In this incident case-control study (n = 150), we defined incident cases as acute stroke patients who developed PSD and controls as acute stroke patients who remained free from dementia at a 6 month follow-up, matched on age, prestroke cognitive status, and number of stroke-related lesions. MRI was performed at initial clinical presentation; neuropsychological assessments and clinical diagnosis of PSD was performed 6 months poststroke. Moderated mediation analysis evaluated the interactions among PSD, anatomical lesions, cognitive domains, and individual demographic and medical characteristics.

Results

Compared to stroke-related lesions, prestroke lesions were associated with the widest range of cognitive domain impairments and had stronger clinical utility in predicting incident PSD. Specifically, global cortical atrophy (GCA) and deep white matter hyperintensities (WMH) were indirectly associated with PSD by disrupting executive functions, memory, and language. Acute infarcts were indirectly associated with PSD by disrupting executive functions and language. The strongest mediator was executive dysfunction, increasing risk of PSD in patients with deep WMH, GCA, and large infarcts by more than 9 times, with sex and educational attainment moderating the magnitude of association. Periventricular WMH were directly associated with incident PSD but not mediated by deficits in cognitive domains.

Conclusion

We provide an anatomical–cognitive framework that can be applied to stratify patients at highest risk of PSD and to guide personalized interventions.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Mok VC, Lam BY, Wang Z, et al. Delayed-onset dementia after stroke or transient ischemic attack. Alzheimers Dement 2016;12:1167–1176.
2.
Kandiah N, Chander RJ, Lin X, et al. Cognitive impairment after mild stroke: development and validation of the SIGNAL2 Risk Score. J Alzheimers Dis 2016;49:1169–1177.
3.
Pohjasvaara T, Mäntylä R, Salonen O, et al. How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia. Arch Neurol 2000;57:1295–1300.
4.
Sachdev PS, Brodaty H, Valenzuela M, et al. The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients. Neurology 2004;62:912–919.
5.
Gottesman RF, Hillis AE. Predictors and assessment of cognitive dysfunction resulting from ischaemic stroke. Lancet Neurol 2010;9:895–905.
6.
Hurford R, Charidimou A, Fox Z, Cipolotti L, Werring DJ. Domain-specific trends in cognitive impairment after acute ischaemic stroke. J Neurol 2013;260:237–241.
7.
Román GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol 2002;1:426–436.
8.
Jokinen H, Kalska H, Mäntylä R, et al. White matter hyperintensities as a predictor of neuropsychological deficits post-stroke. J Neurol Neurosurg Psychiatry 2005;76:1229–1233.
9.
Swartz RH, Stuss DT, Gao F, Black SE. Independent cognitive effects of atrophy and diffuse subcortical and thalamico-cortical cerebrovascular disease in dementia. Stroke 2008;39:822–830.
10.
Hoffmann M. Higher cortical function deficits after stroke: an analysis of 1,000 patients from a dedicated cognitive stroke registry. Neurorehabil Neural Repair 2001;15:113–127.
11.
Hillis AE, Newhart M, Heidler J, Barker PB, Herskovits EH, Degaonkar M. Anatomy of spatial attention: insights from perfusion imaging and hemispatial neglect in acute stroke. J Neurosci 2005;25:3161–3167.
12.
Nys G, Van Zandvoort M, De Kort P, Jansen B, De Haan E, Kappelle L. Cognitive disorders in acute stroke: prevalence and clinical determinants. Cerebrovasc Dis 2007;23:408–416.
13.
Rasquin S, Verhey F, Van Oostenbrugge R, Lousberg R, Lodder J. Demographic and CT scan features related to cognitive impairment in the first year after stroke. J Neurol Neurosurg Psychiatry 2004;75:1562–1567.
14.
Renjen PN, Gauba C, Chaudhari D. Cognitive impairment after stroke. Cureus 2015;7:e335.
15.
Chen X, Duan L, Han Y, et al. Predictors for vascular cognitive impairment in stroke patients. BMC Neurol 2016;16:115.
16.
Downhill JE Jr, Robinson RG. Longitudinal assessment of depression and cognitive impairment following stroke. J Nervous Ment Dis 1994;182:425–431.
17.
Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia diagnostic criteria for research studies: report of the NINDS-AIREN international workshop. Neurology 1993;43:250.
18.
Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century. Stroke 2013;44:2064–2089.
19.
Jorm A, Jacomb P. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med 1989;19:1015–1022.
20.
Van Swieten J, Koudstaal P, Visser M, Schouten H, Van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604–607.
21.
Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann 2002;32:509–515.
22.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed. Arlington: American Psychiatric Association; 2013.
23.
D'Agostino RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care. Circulation 2008;117:743–753.
24.
Dubuois B, Slachevsky A, Litvan I, Pillon B. The FAB A frontal assessment battery at bedside. Neurology 2000;55:1621–1626.
25.
Wechsler D. Wechsler Memory Scale (WMS-IV). New York: The Psychological Corporation; 2009.
26.
Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. Am J Neuroradiol 1987;8:421–426.
27.
Pasquier F, Leys D, Weerts JG, Mounier-Vehier F, Barkhof F, Scheltens P. Inter-and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol 1996;36:268–272.
28.
Hayes AF. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach. New York: Guilford Press; 2013.
29.
Shrout PE, Bolger N. Mediation in experimental and nonexperimental studies: new procedures and recommendations. Psychol Methods 2002;7:422.
30.
MacKinnon DP, Lockwood CM, Williams J. Confidence limits for the indirect effect: distribution of the product and resampling methods. Multivariate Behav Res 2004;39:99.
31.
Staals J, Makin SD, Doubal FN, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology 2014;83:1228–1234.
32.
Sahadevan S, Tan NJ, Tan T, Tan S. Cognitive testing of elderly Chinese people in Singapore: influence of education and age on normative scores. Age Ageing 1997;26:481–486.
33.
Sullivan GM, Feinn R. Using effect size: or why the p value is not enough. J Grad Med Educ 2012;4:279–282.
34.
Burton EJ, Kenny RA, O'Brien J, et al. White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients. Stroke 2004;35:1270–1275.
35.
Kandiah N, Wiryasaputra L, Narasimhalu K, et al. Frontal subcortical ischemia is crucial for post stroke cognitive impairment. J Neurol Sci 2011;309:92–95.
36.
Mok VC, Lam BY, Wong A, Ko H, Markus HS, Wong LK. Early-onset and delayed-onset poststroke dementia: revisiting the mechanisms. Nat Rev Neurol 2017;13:148.
37.
Nys G, Van Zandvoort M, De Kort P, et al. Domain-specific cognitive recovery after first-ever stroke: a follow-up study of 111 cases. J Int Neuropsychological Soc 2005;11:795–806.
38.
Geerlings MI, Appelman AP, Vincken KL, Mali WP. Association of white matter lesions and lacunar infarcts with executive functioning: the SMART-MR study. Am J Epidemiol 2009;170:1147–1155.
39.
Yang J, Wong A, Wang Z, et al. Risk factors for incident dementia after stroke and transient ischemic attack. Alzheimers Dement 2015;11:16–23.

Information & Authors

Information

Published In

Neurology®
Volume 91Number 1July 3, 2018
Pages: e45-e54
PubMed: 29802171

Publication History

Received: November 6, 2017
Accepted: April 3, 2018
Published online: May 25, 2018
Published in print: July 3, 2018

Permissions

Request permissions for this article.

Disclosure

The authors report no disclosures relevant to the manuscript. Go to Neurology.org/N for full disclosures.

Study Funding

A*STAR Biomedical Research Council, Singapore (BMRC 04/1/36/372).

Authors

Affiliations & Disclosures

Chathuri Yatawara, PhD
From the Department of Neurology (C.Y., K.P.N., R.C., N.K.), National Neuroscience Institute; and Duke-NUS (N.K.), Singapore.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Kok Pin Ng, MRCP
From the Department of Neurology (C.Y., K.P.N., R.C., N.K.), National Neuroscience Institute; and Duke-NUS (N.K.), Singapore.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Russell Chander, BA
From the Department of Neurology (C.Y., K.P.N., R.C., N.K.), National Neuroscience Institute; and Duke-NUS (N.K.), Singapore.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Nagaendran Kandiah, FRCP
From the Department of Neurology (C.Y., K.P.N., R.C., N.K.), National Neuroscience Institute; and Duke-NUS (N.K.), Singapore.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Honorarium for speaking engagements from Eisai, Novartis, Lundbeck, Schwabbe, Pfeizer
Editorial Boards:
1.
Journal of Alzheimer's Disease
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
Have received research support form Novartis, Tau Rx, Eisai
Research Support, Government Entities:
1.
Research funding support from National Medical Research Council, Singapore, Singhealth Foundation, Biomedical Research Council, Singapore
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
Temasek Cares Singapore
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE

Notes

Correspondence Prof. Kandiah [email protected]
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

Author Contributions

Dr. Yatawara: study concept and design, statistical analysis, and drafting manuscript. K.P. Pin: drafting manuscript and revising manuscript for intellectual content. R. Chander: data management and drafting manuscript. N. Kandiah: study design and revising manuscript for intellectual content.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Leukoaraiosis as a Predictor of Depression and Cognitive Impairment among Stroke Survivors: A Systematic Review, Neurology International, 15, 1, (238-272), (2023).https://doi.org/10.3390/neurolint15010016
    Crossref
  2. Association of Income with Post-Stroke Cognition and the Underlying Neuroanatomical Mechanism, Brain Sciences, 13, 2, (363), (2023).https://doi.org/10.3390/brainsci13020363
    Crossref
  3. Trends in cognitive function before and after stroke in China, BMC Medicine, 21, 1, (2023).https://doi.org/10.1186/s12916-023-02908-5
    Crossref
  4. Cognitive Outcomes Poststroke: A Need for Better Insights into Mechanisms, Brain Connectivity, 13, 8, (438-440), (2023).https://doi.org/10.1089/brain.2023.29054.editorial
    Crossref
  5. How do cardiovascular risk factors correlate with post-stroke cognitive function: Directly or indirectly through stroke severity?, Frontiers in Neurology, 13, (2022).https://doi.org/10.3389/fneur.2022.917295
    Crossref
  6. Prediction of post-stroke cognitive impairment by Montreal Cognitive Assessment (MoCA) performances in acute stroke: comparison of three normative datasets, Aging Clinical and Experimental Research, 34, 8, (1855-1863), (2022).https://doi.org/10.1007/s40520-022-02133-9
    Crossref
  7. White matter hyperintensities and longitudinal cognitive decline in cognitively normal populations and across diagnostic categories: A meta‐analysis, systematic review, and recommendations for future study harmonization, Alzheimer's & Dementia, 19, 1, (194-207), (2022).https://doi.org/10.1002/alz.12642
    Crossref
  8. Dengzhanxixin Injection Ameliorates Cognitive Impairment Through a Neuroprotective Mechanism Based on Mitochondrial Preservation in Patients With Acute Ischemic Stroke, Frontiers in Pharmacology, 12, (2021).https://doi.org/10.3389/fphar.2021.712436
    Crossref
  9. Soluble ST2 and risk of cognitive impairment after acute ischemic stroke: a prospective observational study, BMC Geriatrics, 21, 1, (2021).https://doi.org/10.1186/s12877-021-02288-6
    Crossref
  10. Microvessel stenosis, enlarged perivascular spaces, and fibrinogen deposition are associated with ischemic periventricular white matter hyperintensities, Brain Pathology, 32, 1, (2021).https://doi.org/10.1111/bpa.13017
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to get full access to it.

Purchase Access, $39 for 24hr of access

View options

Short Form

View Short Form

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share